June 14, 2024

Salk Institute mourns the loss of John Adler, friend and former trustee

Salk News

Salk Institute mourns the loss of John Adler, friend and former trustee

LA JOLLA—The Salk Institute mourns the loss of businessman and philanthropist John Adler, who served on the Institute’s Board of Trustees from 1991 to 2004. He died June 11, 2024, in Greenwich, Connecticut at the age of 96.

John Adler
John Adler
Click here for a high-resolution image.
Credit: Salk Institute

Adler generously supported the Salk Institute for decades, donating $6.7 million to launch the Adler Foundation Symposium on Alzheimer’s Disease Endowment, establish the Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease, and support many other research efforts.

For more than 30 years, the annual Adler Symposium brought together scientists working on different aspects of Alzheimer’s disease to share ideas and build new collaborations.

Professor Rusty Gage, former Salk president, currently holds the Vi and John Adler Chair. His team reprograms skin and other cells from patients with neurologic and psychiatric diseases into induced pluripotent stem cells, induced neurons, and organoids. With these tools, they are deciphering the mechanisms that lead to neurological disorders such as Alzheimer's Disease and exploring new therapeutic approaches.

"John was an outstanding trustee for Salk, for many years,” Gage says. “His sage counsel and generosity of time and resources have benefited the Institute immensely. His legacy of the Adler Symposium, focusing on age-related neurodegenerative diseases, has brought international acclaim to the Salk Institute, forging strong bonds and research collaborations around the world. We are grateful that John was part of our community."

Adler’s family asks that donations in his memory be made to the Salk Institute at www.salk.edu/donate.

For More Information

Office of Communications
Tel: (858) 453-4100

The Salk Institute For Biological Studies:

Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.